Geni Herbs Announces Upcoming Pomegranate Research

Current studies on PomElla involve phase-2 human clinical trials exploring the compound’s effect on heart disease risk factors in individuals with cardiovascular problems, as well as its in vivo antioxidant capacity and bioavailability. Results for these studies are expected by the end of 2005.

“The potential for PomElla is huge, especially given the scientific evidence that has been coming out regarding the synergistic effects of pomegranate, as well its ability to help control manifestations of oxidative stress,” said Lal Hingorani, Ph.D., director of research & development at Pharmanza Herbals, the manufacturing division of Geni Herbs.

For more information, visit www.geniherbs.com or Booth #6054-6056 at SupplySide West.

Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines